Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE Study.

Saved in:
Bibliographic Details
Title: Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE Study.
Authors: Lugogo NL; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA., Akuthota P; Division of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, La Jolla, CA, USA., Sumino K; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Mathur SK; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin, Madison, WI, USA., Burnette AF; Division of Allergy and Immunology, Howard University, Washington, DC, USA., Lindsley AW; US Medical Affairs, Amgen, Thousand Oaks, CA, USA., Llanos JP; Global Medical Affairs, Amgen, Thousand Oaks, CA, USA., Marchese C; Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA., Emmanuel B; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA. benjamin.emmanuel@astrazeneca.com.
Source: Advances in therapy [Adv Ther] 2025 Jul; Vol. 42 (7), pp. 3334-3353. Date of Electronic Publication: 2025 May 19.
Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase IV
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1865-8652
DOI:10.1007/s12325-025-03231-6